This Week at FDA: FDA's final LDT rule nears, Cardinal Health warning letter, and more
Regulatory Affairs Professionals Society | RAPS -

Welcome to another installment of This Week at FDA, your weekly source for updates @ big and small @ on FDA, drug, and medical device regulation, and what we@re reading from around the web. This week, we learned that FDA@s final rule on laboratory developed tests (LDTs) may soon see the light of day. @

Related Articles

Latest in News

More from Regulatory Affairs Professionals Society | RAPS | Food and Drug Administration Laboratory developed test Medicine